木瓜直播

Outcome data still awaited after positive interim results

Additional patients in pivotal trial add to strength of the findings

TAVR, SAVR result in similar outcomes in female-dominated VIVA randomized trial

Study shows better-than-expected benefit for expanded criteria cohort

Pressure-controlled intermittent coronary sinus occlusion appears safe in acute MI, though

T-PASS trial weighs stopping aspirin within a month

Agent device avoids additional layer of stenting in patients with recurrent blockages

Improved limb salvage and primary patency possible with endovascular approach

Will preliminary results be confirmed by SUMMIT trial to come?

JenaValve device hits benchmarks with improvement in pacemaker rates

WATCH-TAVR suggests percutaneous approach can follow surgical pattern in not staging procedures

The two devices continue to lead to similar clinical outcomes

Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials

Question now is whether routine early treatment will translate to better clinical outcomes